Display Settings:

Format

Send to:

Choose Destination

    Neurology. 2005 Sep 13;65(5):741-4.

    A clinic-based study of the LRRK2 gene in Parkinson disease yields new mutations.

    Zabetian CP, Samii A, Mosley AD, Roberts JW, Leis BC, Yearout D, Raskind WH, Griffith A.

    Department of Neurology, University of Washington School of Medicine, Seattle, WA, USA. zabetian@u.washington.edu

    Comment in:

    Referral-based studies indicate that a mutation (G2019S) in exon 41 of the LRRK2 gene might be a common cause of Parkinson disease (PD). The authors sequenced leucine-rich repeat kinase 2 (LRRK2) exons 31, 35, and 41 in 371 consecutively recruited patients with PD and found mutations in six (1.6%) subjects, including two heterozygous for new putative pathogenic variants (R1441H, IVS31 + 3A-->G). These data confirm the important contribution of LRRK2 to PD susceptibility in a clinic-based population.

    PMID: 16157909 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read